From July 1965 until November 1971, New Zealand Defence Force Personnel fought in the Vietnam War. During this time more than 76,500,000 litres of phenoxylic herbicides were sprayed over parts of Southern Vietnam and Laos, the most common being known as ‘Agent Orange’. The current study aimed to ascertain whether or not New Zealand Vietnam War veterans show evidence of genetic disturbance arising as a consequence of their now confirmed exposure to these defoliants. A sample group of 24 New Zealand Vietnam War veterans and 23 control volunteers were compared using an SCE (sister chromatid exchange) analysis. The results from the SCE study show a highly significant difference (P < 0.001) between the mean of the experimental group (11.05) and the mean of a matched control group (8.18). The experimental group also has an exceptionally high proportion of HFCs (cells with high SCE frequencies) above the 95th percentile compared to the controls (11.0 and 0.07%, respectively). We conclude that the New Zealand Vietnam War veterans studied here were exposed to a clastogenic substance(s) which continues to exert an observable genetic effect today, and suggest that this is attributable to their service in Vietnam.

1.
Akhtar FZ, Garabrant DH, Ketchum NS, Michalek JE: Cancer in US Air Force veterans of the Vietnam war. J Occup Env Health 46:123–136 (2004).
2.
Akin A, Ugur F, Ozkul Y, Esmaoglu A, Gunes I, Ergul H: Desflurane anaesthesia increases sister chromatid exchanges in human lymphocytes. Acta Anaest Scand 49:1559–1561 (2005).
3.
Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K, et al: IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. Mutat Res 463:111–172 (2000).
4.
Arias E: Sister chromatid exchange, induction by the herbicide 2,4-dichlorophenoxyacetic acid in chick embryos. Ecotoxicol Env Safety 55:338–343 (2003).
5.
Bhattacharya K, Dopp E, Kakkar P, Jaffery FN, Schiffmann D, et al: Biomarkers in risk assessment of asbestos exposure. Mutat Res 579:6–21 (2005).
6.
Bukowska B: 2,4,5-T and 2,4,5-TCP induce oxidative damage in human erythrocytes: the role of glutathione. Cell Biol Int 28:557–563 (2004).
7.
Carrano AV, Natarajan AT: Considerations for population monitoring using cytogenetic techniques. Mutat Res 204:379–406 (1988).
8.
Chadwick S: Inquiry into the exposure of New Zealand defence personnel to Agent Orange and other defoliant chemicals during the Vietnam War and any health effects of the exposure, and transcripts of evidence. House of Representatives, Wellington (2004).
9.
Cohen J: Statistical Power Analysis for the Behavioural Sciences (Lawrence Erlbaum Associates, Hillsdale 1988).
10.
Duchnowicz P, Szczepaniak P, Koter M: Erythrocyte membrane protein damage by phenoxyacetic herbicides and their metabolites. Pest Biochem Phys 82:59–65 (2005).
11.
Eriksson M, Hardell L, Berg NO, Moller T, Axelson O: Soft-tissue sarcomas and exposure to chemical-substances – a case-referent study. Br J Indust Med 38:27–33 (1981).
12.
Fowles J, Gallagher L, Baker V, Phillip D, Marriott F, et al: A study of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposures in Paritutu, New Zealand. Report to the New Zealand Ministry of Health (2005).
13.
Garaj-Vrhovac V, Zeljezic D: Cytogenetic monitoring of Croatian population occupationally exposed to a complex mixture of pesticides. Toxicol 165:153–162 (2001).
14.
Geyer H, Schramm K, Feicht E, Behechti A, Steinberg C, et al: Half-lives of tetra-, penta-, hexa-, hepta-, and octachlorodibenzo-p-dioxin in rats, monkeys, and humans – a critical review. Chemosphere 48:631–644 (2002).
15.
Hardell L, Sandstrom A: Case-control study – soft-tissue sarcomas and exposure to phenoxyacetic acids or chlorophenols. Br J Cancer 39:711–717 (1979).
16.
Iannuzzi L, Perucatti A, Di Meo GP, Polimeno F, Ciotola F, et al: Chromosome fragility in two sheep flocks exposed to dioxins during pasturage. Mutagenesis 19:355–359 (2004).
17.
Karaoguz MY, Cosar B, Arikan Z, Basaran F, Menevse A, Menevse S: Increased frequency of sister chromatid exchanges in peripheral lymphocytes of alcoholics and cigarette smokers. Cell Biol Int 29:165–168 (2005).
18.
Lazutka JR, Dedonyte V, Lekevicius RK: Sister chromatid exchanges in lymphocytes of normal and alcoholic subjects. Experientia 48:508–512 (1992).
19.
Palmer MG: The legacy of agent orange: empirical evidence from central Vietnam. Soc Sci Med 60:1061–1070 (2005).
20.
Schecter A, Dai LC, Thuy L, Quynh HT, Minh DQ, et al: Agent orange and the Vietnamese: The persistence of elevated dioxin levels in human tissues. Am J Public Health 85:516–522 (1995).
21.
Stellman J, Stellman S, Christian R, Weber T, Tomasallo C: The extent and patterns of usage of Agent Orange and other herbicides in Vietnam. Nature 422:681–687 (2003).
22.
Tabachnick BG, Fidell LS: Using Multivariate Statistics, 4th Ed. (Harper Collins, New York 2001).
23.
Wolff S, Perry P: Insights on chromosome structure from sister chromatid exchange ratios and lack of both isolabeling and heterolabeling as determined by the FPG technique. Exp Cell Res 93:23–30 (1975).
24.
Zober A, Ott MG, Fleig I, Heidemann A: Cytogenetic studies in lymphocytes of workers exposed to 2,3,7,8-TCDD. Int Arch Occup Env Health 65:157–161 (1993).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.